1. Home
  2. LASR vs AMRX Comparison

LASR vs AMRX Comparison

Compare LASR & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo nLIGHT Inc.

LASR

nLIGHT Inc.

HOLD

Current Price

$64.73

Market Cap

3.7B

Sector

Technology

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$16.21

Market Cap

4.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LASR
AMRX
Founded
2000
2002
Country
United States
United States
Employees
800
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
4.0B
IPO Year
2018
2018

Fundamental Metrics

Financial Performance
Metric
LASR
AMRX
Price
$64.73
$16.21
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
5
Target Price
$54.31
$15.60
AVG Volume (30 Days)
990.9K
1.8M
Earning Date
05-07-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
62.99
157.89
EPS
0.01
0.19
Revenue
$191,359,000.00
N/A
Revenue This Year
$10.91
$4.48
Revenue Next Year
$14.32
$7.13
P/E Ratio
$6,488.00
$84.29
Revenue Growth
38.09
N/A
52 Week Low
$16.87
$7.67
52 Week High
$86.95
$16.61

Technical Indicators

Market Signals
Indicator
LASR
AMRX
Relative Strength Index (RSI) 42.20 78.56
Support Level $63.48 $12.46
Resistance Level $71.81 N/A
Average True Range (ATR) 5.43 0.57
MACD -0.84 0.27
Stochastic Oscillator 24.88 90.29

Price Performance

Historical Comparison
LASR
AMRX

About LASR nLIGHT Inc.

nLight Inc is a United States-based company provider of power semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It designs, manufactures, and sells a range of power semiconductor lasers and fiber lasers that are typically integrated into laser systems. It operates in two segments: Laser Products segment, which includes semiconductor lasers, fiber lasers, and directed energy products; and Advanced Development segment includes revenue earned from research and development contracts. The majority of its revenue is generated from the Laser segment. The company's geographical segments include North America, Asia Pacific, and EMEA, of which maximum revenue is derived from North America.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: